About Alteus Global Limited
Data last updated:
Alteus Global Limited is a public limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24304WB2021PLC249646. Its GSTIN is 19AAWCA1271E1ZI (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Nibedita Chakraborty and Soma Dev.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14B Dover Lane 1st Floor, Kolkata, West Bengal, India – 700029.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.8 Cr, a decline of 48% compared to the previous year. For the same year it recorded a net profit of ₹24.81 Lakh (net margin 4.3%) and EBITDA of ₹35.94 Lakh (EBITDA margin 6.2%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years.
Its group structure includes 2 subsidiaries.
For more details, the company can be reached via its website alteus.co.in.
Company details
Contact details
Alteus Global Limited's registered office is in Kolkata, West Bengal. Its website is alteus.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address14B Dover Lane 1st Floor, Kolkata, West Bengal, India – 700029
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alteus Global Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Alteus Global Limited
FY 2025 filings availableAlteus Global Limited reported revenue of ₹5.8 Cr (down 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 23% over three years, including a 48% fall in the latest year. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹35.94 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹24.81 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.2% | |||
| Net Profit Margin | 4.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Alteus Global Limited, buy the company report.
Board of directors of Alteus Global Limited
Alteus Global has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nibedita Chakraborty Also directs: Alteus Life Limited, Alteus Biogenics Private Limited, G99 Pharmacy Limited and 4 more | Director | 17 Nov 2021 | 4 Years 11 Months | Current |
| Soma Dev Also directs: Alteus Life Limited, Alteus Biogenics Private Limited, G99 Pharmacy Limited and 5 more | Director | 17 Nov 2021 | 4 Years 11 Months | Current |
| Debasish Mitra Also directs: Alteus Life Limited, Alteus Biogenics Private Limited, G99 Pharmacy Limited and 5 more | Director | 17 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Alteus Global Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Turret Pharma Private Limited | ₹5.84 Cr (FY 2024) | 26.0% | Aurangabad, Maharashtra, India | |||
| Medios Laboratories Private Limited | ₹5.83 Cr (FY 2025) | 7.0% | Baddi, Himachal Pradesh, India | |||
| Ronak Life Care Private Limited | ₹5.83 Cr (FY 2025) | -2.0% | Ahmedabad, Gujarat, India | |||
| Zatine Cosmocon Pharma Private Limited | ₹5.83 Cr (FY 2025) | 9.0% | Hubli, Karnataka, India | |||
| Aaryveda Global Healthcare (I) Private Limited | ₹5.81 Cr (FY 2024) | Pune, Maharashtra, India | ||||
| Alteus Global Limitedthis company | ₹5.8 Cr (FY 2025) | ₹24.81 Lakh | 4.3% | -48.0% | Kolkata, West Bengal, India | |
| Lxora Lifesciences Private Limited | ₹5.79 Cr (FY 2025) | 24.0% | Panchkula, Haryana, India | |||
| Nucleus Formulation Private Limited | ₹5.79 Cr (FY 2025) | 14.0% | Chhatral, Gujarat, India | |||
| Bio Resource Biotech Private Limited | ₹5.78 Cr (FY 2025) | -27.0% | Pune, Maharashtra, India | |||
| Trexgen Pharmaceuticals Private Limited | ₹5.78 Cr (FY 2024) | 10.0% | Ahmedabad, Gujarat, India | |||
| Alpic Biotech Limited | ₹5.77 Cr (FY 2025) | -30.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Alteus Global Limited, buy the company report.
Auditor
Alteus Global Limited is audited by Damle Dhandhania & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Damle Dhandhania & Co. | FY 2023 | 325361E |
Shareholding
The shareholding of Alteus Global Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Alteus Global Limited, buy the company report.
Legal cases
No court or tribunal cases involving Alteus Global Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alteus Global Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Alteus Global has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Alteus Laboratories Private Limited | U85190WB2020PTC240408 | |
| Alteus Sons Private Limited | U85190WB2021PTC244334 |
To see the full group structure of Alteus Global Limited, buy the company report.
Employees & EPFO
Alteus Global Limited has 1 active EPFO establishment as of Mar 29, 2024.
GST
Alteus Global has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAWCA1271E1ZI | West Bengal | Active | 28 Aug 2024 |
To see the full GST registrations and return filing status of Alteus Global Limited, buy the company report.
Recent activity
Alteus Global Limited has 3 board changes on record since 2021: 3 appointments. The latest: Debasish Mitra was appointed as Director on 17 Nov 2021.
Frequently asked questions
Alteus Global is an active public limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 November 2021 (5+ years old) and is registered under CIN U24304WB2021PLC249646.
Alteus Global has 3 current directors:
- Nibedita Chakraborty - Director
- Soma Dev - Director
- Debasish Mitra - Director
The latest financial statements of Alteus Global on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Alteus Global is 19AAWCA1271E1ZI, registered in West Bengal.
The CIN (Corporate Identification Number) of Alteus Global is U24304WB2021PLC249646. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alteus Global was incorporated on 17 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Alteus Global by revenue are Turret Pharma Private Limited, Medios Laboratories Private Limited, Ronak Life Care Private Limited, Zatine Cosmocon Pharma Private Limited, Aaryveda Global Healthcare (I) Private Limited and 5 more, all in the Pharma industry (Formulations).
Debasish Mitra was appointed as Director on 17 Nov 2021. Nibedita Chakraborty was appointed as Director on 17 Nov 2021. Soma Dev was appointed as Director on 17 Nov 2021.
Alteus Global can be reached through the website alteus.co.in. Its registered office is in Kolkata, West Bengal, India.
The registered office of Alteus Global is at 14B Dover Lane 1st Floor, Kolkata, West Bengal, India – 700029.
Alteus Global operates in the pharma industry, in the drug formulation and development segment.